Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[EX Q]: Peebles, a 30-year-old black man who’s skeptical of what he hears from the news media and government, initially didn’t see the need for alarm over the virus. “I felt it was a complete hoax,” Peebles said. “This thing happens every two or four years. We have an outbreak of a disease that seems to put everybody in a panic.” Peebles is among roughly 40 million black Americans deciding minute by minute whether to put their faith in government and the medical community during the coronavirus pandemic. Historic failures in government responses to disasters and emergencies, medical abuse, neglect and exploitation have jaded generations of black people into a distrust of public institutions. “I’ve just been conditioned not to trust,” said Peebles, who is now obeying the state’s stay home order and keeping his distance from others when he goes out. Some call such skepticism the “Tuskegee effect” — distrust linked to the U.S. government’s once-secret study of black men in Alabama who were left untreated for syphilis. Black people already suffer disproportionately from chronic conditions like diabetes and heart disease and are far more likely to be uninsured. How the government and medical community responds to the crisis will be especially crucial for outcomes among black Americans, civil rights advocates and medical experts say. “We are right to be paranoid and to ask tough questions,” said U.S. Rep. Ayanna Pressley of Massachusetts who joined other congressional leaders in asking the government to collect and release information about the race and ethnicity of people who are tested or treated for the virus that causes COVID-19. “History has shown us, when we do not” ask questions, said Pressley, who is black, “the consequences are grave, and in fact life and death.”  NAACP President Derrick Johnson, who hosted a coronavirus tele-town hall with U.S. Surgeon General Jerome Adams last month, said black and brown communities need reliable information about the crisis. “Now that this has been deemed a pandemic, I am most concerned with inequities in who’s provided tests, who’s provided treatment and how those tests and the treatments are administered, in a way that is open, transparent, and equitable,” Johnson said. For most people, the virus causes mild or moderate symptoms, such as fever and cough. But for some, especially older adults and people with existing health problems, it can cause more severe illness, including pneumonia and death. Cities with large black populations like New York, Chicago, Detroit, Milwaukee and New Orleans have emerged as hot spots for the coronavirus. Figures released by Michigan’s Department of Health and Human Services show 40% of those who have died from COVID-19 are black in a state where African-Americans are just 14% of the population. And many Southern states with large black populations have been slow to mandate statewide restrictions shown to slow virus spread. According to the U.S. Department of Health and Human Services, black adults are 60% more likely than non-Hispanic white adults to be diagnosed with diabetes, 40% more likely to have high blood pressure and are less likely to have those conditions under control. Additionally, in 2015, black women were 20% more likely to have asthma than non-Hispanic whites. Those disparities make the availability of a treatment or vaccine urgent, even as the virus is currently projected to claim tens of thousands of lives. But given history, Peebles said he wouldn’t rush to accept a remedy. “If we got to a place where the government says, ‘OK, now it’s time to take a vaccine,’ then I’m definitely going to be skeptical of their intentions,” he said. Launched in 1932 by the U.S. Public Health Service, the Tuskegee study involved roughly 600 poor black men in Alabama who weren’t treated for the sexually transmitted disease so researchers could track its progress. The program was exposed and ended in 1972, and then-President Bill Clinton formally apologized in 1997. The Tuskegee legacy has helped pollute the black community’s relationship with American medical science. A 2016 paper found the fallout included mistrust of medicine among black men, along with fewer interactions with doctors and higher mortality rates. In Tuskegee, where many families include descendants of victims, many residents don’t trust government health information, said Lucenia Dunn, a former Tuskegee mayor. So volunteers trying to get the word out about coronavirus have gone door-to-door distributing fliers with cartoon-like illustrations that don’t look “too official,” she said. “We have a general distrust in this community,’” Dunn said. “I call it ‘subconscious rejection.’ The attitude is, ‘I’m going to rebel against this. You people have been telling us lies for years. Why should I believe you now?’” In Los Angeles, Jahmil Lacey helped found a public health group for black men and boys, TRAPMedicine, that educates black barbers and organizes workshops to address health disparities among their customers. “People will quote the Tuskegee experiment as the reason why black people don’t trust health care, but there’s so much more than just that one example,” Lacey said. “We don’t trust systems that are connected to white supremacy. So, we have to do the work to repair it.” Indeed, Tuskegee didn’t happen in a vacuum. In the 1950s, doctors at the John Hopkins Hospital used cervical cancer cells from Henrietta Lacks, a black mother of five, to pioneer medical advances and research that continue globally today. Lacks, who died in 1951, never gave her consent and her family has never been compensated. One way to begin healing the mistrust is to increase black representation in the medical field, said Dr. Nicollette Louissaint, executive director of the Washington-based emergency response advocacy group Healthcare Ready. “We have to make sure that ... the message itself and the messengers are being adapted to the appropriate audience,” said Louissaint, who is black. “It’s going to be really important that we get that right.” ___ Reeves reported from Birmingham, Alabama. Both are members of the AP’s Race and Ethnicity team. Follow Morrison on Twitter at http://twitter.com/aaronlmorrison. Follow Reeves on Twitter at https://twitter.com/Jay_Reeves
[EX A]: Amid coronavirus pandemic, black mistrust of medicine looms.

[EX Q]: The company’s forecast implies a potential $3 billion upgrade to the consensus estimate from analysts and marks an attempt to call a bottom to a sales decline driven by the loss of exclusivity on several top-selling medicines. Britain’s second-biggest drugmaker is already suffering from generic competition to its antipsychotic Seroquel, while its Nexium treatment for excess stomach acid loses U.S. patent cover this year. Top-selling Crestor, for high cholesterol, faces competition from cheap copycat drugs in 2016. The patent expiries leave AstraZeneca’s sales on a near-term downward spiral at a time when most of its rivals have put their biggest patent losses behind them. Shares in the group rose 1.6 percent by 1215 GMT on the more upbeat outlook, against a 0.3 percent decline for the European healthcare sector. Chief Executive Pascal Soriot, who has been leading the company for a little more than a year, will set out the new revenue guidance in a presentation at the J.P. Morgan Healthcare conference in San Francisco later on Tuesday. The company will then give a more detailed update on its progress in full-year results on February 6. The consensus of analyst forecasts compiled by Thomson Reuters is for 2017 revenue of $22.5 billion, down from the $25.8 billion estimated for 2013. However, a number of the 2017 forecasts pre-date the diabetes drug deal struck last month that is already expected to add some $1 billion to $2 billion to annual revenue. Citigroup analyst Andrew Baum said the positive medium-term outlook reinforced his “more constructive thesis” for the stock, adding that he expects Soriot to strike more earnings-boosting deals this year. Panmure Gordon’s Savvas Neophytou remains more wary, pointing out that Soriot’s predecessor, David Brennan, had made a similar attempt to talk up AstraZeneca’s longer-term prospects. “In our view, management is stepping onto thin ice with this same sort of guidance,” Neophytou said, pointing out the previous management’s failure to hit its forecasts. AstraZeneca has become more confident about its revenue outlook after the $4 billion deal last month to buy Bristol-Myers Squibb’s share of a diabetes joint venture. The acquisition is expected to complete in the first quarter of 2014 and will boost sales immediately. Mark Clark of Deutsche Bank said this was set to lift analysts’ revenue forecasts significantly, suggesting that a more realistic “adjusted consensus” for 2017 was around $24.3 billion rather than $22.5 billion. Soriot has been striking a number of bolt-on deals to refill the company’s thin pipeline of new medicines and accelerating in-house research programs. The group now has 11 new-drug programs in late-stage Phase III testing, almost double the number a year ago, and 27 in Phase II. Hopes are particularly high for its cancer research, where it has started trials for immunotherapy combination treatments for which the first results are anticipated in 2014/15. AstraZeneca is behind the likes of Bristol-Myers, Roche and Merck & Co in the race to develop immunotherapies - a hot new area of cancer research - but it is betting on combination treatments to help it to catch up. Immunotherapy, which harnesses the body’s immune system to fight cancer, has shown great promise in clinical trials and analysts believe that the treatments may extend patients’ lives significantly and generate tens of billions of dollars in annual sales.
[EX A]: Drugmaker AstraZeneca forecasts faster return to growth.

[EX Q]: About 93 per cent of about 5,000 people surveyed by WWF in March across three Southeast Asian nations as well as Hong Kong and Japan said unregulated markets selling wildlife should be shuttered to ward off future pandemics. Scientists believe the virus that has upturned the lives of billions across the globe originated in a wildlife market, likely in the Chinese city of Wuhan, where bats, pangolins, and other animals known to transmit coronaviruses are crammed together in fetid conditions. “This is no longer a wildlife problem. It is a global security and human health and economic problem,” Christy Williams, WWF’s Asia Pacific Director, said in a news conference, giving results of the survey. Support for a crackdown on markets was strongest in Myanmar, where wildlife has for years been traded openly in the autonomous regions bordering China, while a third of respondents in Vietnam said the crisis had prompted them to stop consuming wildlife products. “COVID is a wake-up call,” Grace Hwa, Illegal Wildlife Trade Programme Manager at WWF Myanmar, said in a statement. “The rampant unchecked trade in wildlife is a risk not only to health and the economy, but to the entire stability of the region.”  In the wake of the outbreak, which began in Wuhan and has since spanned the globe, China introduced a ban on all farming and consumption of live wildlife, but it does not cover the trade in animals as pets, and for traditional medicine. Vietnam’s prime minister has ordered the agriculture ministry to draft a similar directive, banning wildlife trade and consumption. Jeremy Douglas, Southeast Asia and Pacific representative for the U.N office on drugs and crime, said some of the trade had been driven underground. “I’m really concerned about the special regions,” he told Reuters by phone, referring to autonomous zones on the Myanmar-China border controlled by ethnic armed groups which have long been a hub for wildlife trafficking. Two residents of Mong La, a border town known as a hotbed of smuggling, told Reuters by phone the markets remained open but wildlife shops were shut. “It is because the car routes are closed so the trade route cannot be done,” said Ye Min Tun, a 29-year-old construction worker.
[EX A]:
After-coronavirus, SE Asia strongly favours crackdown on wildlife trade, says WWF.